C. Roehrborn, P. Boyle, and J. Nickel, Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia, Urology, vol.60, issue.3, pp.434-438, 2002.
DOI : 10.1016/S0090-4295(02)01905-2